NCT03471338
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
- Locations
-
- University Hospital of Caen Caen, Calvados, France
Clinical trial condition
Secondary Progressive Multiple Sclerosis
Explore clinical trials studying Secondary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
42 public trials
3 recruiting studies
Secondary Progressive Multiple Sclerosis trial results
NCT05349474
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
NCT03896217
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Department of Neuroinflammation, UCL Institute of Neurology London, United Kingdom
NCT06588387
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT06526000
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT04792567
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +22 more
- Locations
-
- Novartis Investigative Site Mittweida, Saxony, Germany
- Novartis Investigative Site Bogen, Germany
- Novartis Investigative Site Chemnitz, Germany
- Novartis Investigative Site Dresden, Germany
NCT01665144
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Berkeley, California, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Oceanside, California, United States
NCT06395909
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Completed
Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGo
NCT05826028
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Novartis Investigational Site Camperdown, New South Wales, Australia
- Novartis Investigational Site St Leonards, New South Wales, Australia
NCT02207075
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Weill Cornell Medical College New York, United States